国产精品美女久久久9999丨97精品国产自产在线观看永久丨无码一区二区三区不卡av丨亚洲国产成人手机在线电影丨一区二区三区最新地址

[Print page][Close page][Font Size: BigNormalSmall]

Integration: Reinforcing the industrial system

Date:2024-05-30 10:20|Source: |Visits:

The openness of SIP has allowed it to attract resources from around the globe, which has laid a good foundation for the development of the medical device industry.

Double wheels to drive the industry

In SIP, opening-up and innovation are well integrated. International cooperation has allowed multinationals to accelerate localization in SIP, and local enterprises to gain advanced concepts, technologies and experience.

The cooperation between Johnson & Johnson and Chinese Academy of Sciences’ Suzhou Institute of Nano-tech and Nano-bionics in medical coating technology has entered the third phase, and both Eli Lilly and Company and Danaher have made investments in biomedicine enterprises in SIP.

Efforts to build an assisted reproductive technology industry chain

Basecare, founded in SIP in 2010, has brought into market its new testing kit for preimplantation genetic screening (PGS) aimed at detecting chromosome abnormalities of IVF (in-vitro fertilization) embryos. The company is striving to build an assisted reproductive technology industry chain.

Last June, Basecare acquired Genea Biomedx, world-famous fertility group Genea’s high-end medical devices arm in Singapore. And one month later, it signed an agreement with Genea to launch strategic cooperation in global marketing and introduction of advanced products to China.

According to CFO Yin Lejun, in addition to accelerating R&D and manufacturing of its own products, the company would enhance efforts to integrate upstream and downstream resources through SIP’s platforms to propel stronger development of the assisted reproductive technology industry.

Accelerating clinical application of new products

In this aspect, Suzhou Rainmed Medical Technology Co Ltd, which was founded in 2014, set a good example. Based on its advanced medical imaging algorithms, fluid dynamics analysis, mechanical design and R&D of interventional consumables, it has developed a pipeline of industry-leading products.

Suzhou Rainmed Medical Technology has made success in commercializing its FlashAngio caFFR System, a coronary angiography-derived fractional flow reserve measurement system, and FlashAngio caIMR System, a device for measurement of coronary angiography-derived index of microvascular resistance (caIMR).

The company has established partnerships with many hospitals to cooperate in commercializing its products. So far, its products have been used by over 1,300 hospitals in 30 provincial-level regions in China and 15 other countries and regions.

主站蜘蛛池模板: 西贡区| 黄山市| 许昌县| 寻甸| 成武县| 剑川县| 青河县| 临夏县| 广东省| 平远县| 岳普湖县| 通化县| 荆州市| 泸水县| 毕节市| 榕江县| 四川省| 临安市| 百色市| 石阡县| 枝江市| 鸡泽县| 大埔县| 泰宁县| 体育| 澄城县| 台南县| 汕尾市| 八宿县| 昌都县| 秦安县| 大洼县| 乡城县| 阿图什市| 开江县| 莱芜市| 那曲县| 依安县| 舟山市| 安图县| 饶阳县|